Israel Englander’s MacroGenics MGNX Stock Holding History

Israel Englander’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,500	Closed	-$313K	–	7280
2022 Q1	$313K	Buy	+35,500	New	+$392K	﹤0.01%	5495
2020 Q3	–	Sell	-27,500	Closed	-$768K	–	4678
2020 Q2	$768K	Hold	27,500	–	–	﹤0.01%	3148
2020 Q1	$160K	Sell	27,500 -272,500	-91%	-$2.47M	﹤0.01%	3462
2019 Q4	$3.26M	Hold	300,000	–	–	﹤0.01%	2257
2019 Q3	$3.83M	Buy	+300,000	New	+$4.32M	0.01%	2009

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Israel Englander's MGNX Position: Q2 2026 in Review

Israel Englander reduced its MacroGenics (MGNX) stake by 15% in Q2 2026, selling an estimated $1.59M and leaving 2,374,296 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #2195.

Israel Englander first reported a position in MGNX in Q1 2014 and has held it in 50 quarters since. The position peaked at $50M in Q2 2019. 121 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Israel Englander held 2,374,296 shares of MacroGenics worth $11M as of Q2 2026.
Israel Englander sold 420,061 MacroGenics shares in Q2 2026, an estimated $1.59M.
MacroGenics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2195 holding.
Israel Englander first reported a position in MacroGenics in Q1 2014 and has held it in 50 quarters since.
Israel Englander's MacroGenics position peaked at $50M in Q2 2019.
121 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.